Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07228000 · ClinicalTrials.gov registry record · NA
Bundled Cancer Screening and Genetic Services Navigation
A NA study, sponsored by Georgetown University.
- Recruiting
- Registry status
- NA
- Development phase
- 820
- Enrollment target
NCT07228000: Recruiting NA study, sponsored by Georgetown University.
NCT07228000 is a NA study that is actively recruiting participants, run by Georgetown University. The registered enrollment target is 820 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (42% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07228000, a NA study, is actively recruiting participants, sponsored by Georgetown University.
- RECRUITING
- Registry status
- NA
- Development phase
- 820 participants
- Enrollment target
Study Summary
The goal of this study is to test bundled familial cancer risk assessment + multicancer (colorectal + breast) vs. single (breast) cancer navigation, using a wait list control for colorectal cancer screening referral and navigation. Among those eligible, this study will test usual care referral to genetic services vs. pretest education + usual care referral. The study also will assess how bundled multicancer navigation works and for whom it is most effective through a multisite, mixed-methods patient- and organization-level process evaluation.
Primary Outcome
Colorectal cancer screening will be determined through electronic health records abstraction. Documentation of screening includes the test (FIT, colonoscopy), date, clinical indication, assessment or result (imaging, pathology) and recommendations and procedures as applicable, following to treatment initiation.
Interventions
- BEHAVIORAL Breast cancer screening navigation
- BEHAVIORAL Multicancer screening navigation
- BEHAVIORAL Usual care genetics referral
- BEHAVIORAL Pretest education + usual care genetics referral
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 820 participants |
| Start Date | 2026-05-06 |
| Est. Completion | 2029-05-31 |
| Phase | NA |
What NCT07228000 shows while recruiting
NCT07228000 is an interventional study that assigns participants to a tested intervention. The registered 820 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (42% lower).
The record links to 0 conditions, and to 4 interventions - of which Breast cancer screening navigation is the first listed.
NCT07228000 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07228000 about?
NCT07228000 is a clinical study titled "Bundled Cancer Screening and Genetic Services Navigation". The goal of this study is to test bundled familial cancer risk assessment + multicancer (colorectal + breast) vs. single (breast) cancer navigation, using a wait list control for colorectal cancer screening referral and navigation. Among those eligible, this study will test usual care referral to ge...
What is the current status of trial NCT07228000?
This trial is currently recruiting. It is a NA study. The enrollment target is 820 participants. The study started on 2026-05-06. Estimated completion is 2029-05-31.
What interventions are being tested in trial NCT07228000?
The interventions under investigation include: Breast cancer screening navigation (BEHAVIORAL), Multicancer screening navigation (BEHAVIORAL), Usual care genetics referral (BEHAVIORAL), Pretest education + usual care genetics referral (BEHAVIORAL).
Who is sponsoring clinical trial NCT07228000?
This trial is sponsored by Georgetown University, which has 227 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07228000's enrollment target sits among peer trials
820 134th of 2000 higher than 1,867 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04028687 · 820 participants
MDR - PMCF Study for Taperloc Complete Stems
- NCT04613440 · 820 participants · NA
FaCT Trial (Facilitated Cascade Testing Trial)
- NCT04910269 · 820 participants · Phase 3
Outpatient Treatment With Anti-Coronavirus Immunoglobulin
- NCT05679349 · 822 participants · NA
Support and Outreach to Increase Screening for Lung Cancer in Patients With a History of Smoking
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI